|
Revenues
|
|
$152.2m
|
$320.5m
|
$495.3m
|
$544.0m
|
$276.8m
|
$781.6m
|
$888.4m
|
$709.3m
|
$636.6m
|
|
Cost of sales
|
|
$121.0m
|
$269.1m
|
$370.4m
|
$470.0m
|
$220.1m
|
$621.3m
|
$672.5m
|
$549.7m
|
$501.5m
|
|
Selling, general and administrative
|
|
$60.1m
|
$73.4m
|
$100.4m
|
$100.0m
|
$88.8m
|
$70.4m
|
$86.7m
|
$79.6m
|
$68.5m
|
|
Depreciation and amortization
|
|
—
|
—
|
—
|
—
|
$53.8m
|
$56.8m
|
$72.8m
|
$94.0m
|
$95.2m
|
|
Impairment and other charges
|
|
—
|
—
|
—
|
$47.0m
|
$213.9m
|
$0
|
$0
|
$100k
|
$0
|
|
Operating loss
|
|
($89.5m)
|
($24.0m)
|
$22.1m
|
($75.7m)
|
($301.1m)
|
$32.5m
|
$56.9m
|
($15.5m)
|
($30.3m)
|
|
Interest income
|
|
—
|
—
|
—
|
—
|
—
|
$0
|
($1.8m)
|
($2.5m)
|
($400k)
|
|
Loss on debt extinguishment
|
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
$0
|
$1.2m
|
|
Net loss before income tax
|
|
—
|
—
|
—
|
—
|
($93.5m)
|
($2.5m)
|
$22.2m
|
($52.4m)
|
($76.3m)
|
|
Net loss
|
|
($89.6m)
|
($24.1m)
|
$14.4m
|
($96.4m)
|
($332.2m)
|
($3.1m)
|
$19.2m
|
($53.0m)
|
($77.1m)
|
|
Net loss per share - basic (in dollars per share)
|
|
($4)
|
($1)
|
$1
|
($4)
|
($51)
|
($0)
|
$1
|
($3)
|
($4)
|
|
Net loss per share - diluted (in dollars per share)
|
|
($4)
|
($1)
|
$1
|
($4)
|
($51)
|
($0)
|
$1
|
($3)
|
($4)
|
|
Research and development costs
|
|
$300k
|
$2.0m
|
$2.4m
|
$2.7m
|
$700k
|
$600k
|
$1.4m
|
$1.4m
|
$1.7m
|
|
Interest expense
|
|
—
|
—
|
—
|
—
|
—
|
$35.0m
|
$36.5m
|
$39.4m
|
$45.2m
|
|
Income tax expense
|
|
$100k
|
$100k
|
$600k
|
($8.5m)
|
$400k
|
$600k
|
$3.0m
|
$600k
|
$800k
|